Crafty Hackers? Another week—another data breach class action lawsuit. This one targets Michaels Arts and Crafts stores—where maybe there was a bit too much creativity happening, and not on the sales floor. The company is facing a federal data breach class action lawsuit following the release of its statement announcing customers’ personal information may have been stolen.
Filed by customer and plaintiff Christina Moyer, the Michaels lawsuit, entitled Moyer v. Michaels Stores Inc., Case No. 1:140cv-00561, in the U.S. District Court for the Northern District of Illinois alleges the Texas-based retailer was negligent in protecting customer information. Specifically, Moyer, who shopped at Michaels recently, alleges she is now paying for credit monitoring and identity theft protection because of the possible compromise, and that Michaels breached an implied contract with her and others by failing to adequately protect their private information.
Further, the lawsuit claims Michaels “did not adequately monitor their information technology system for the presence of intruders in a manner that would enable them to detect this intrusion, so that they breach of security and diversion of customer information was able to continue unnoticed fora period of time.”
Moyer is seeking a declaratory judgment that Michaels pay for credit monitoring and identity theft insurance, and be ordered to indemnify Moyer and the class for future harm.
Do you Know Where your Loved Ones are? This is deeply creepy—in so many ways…. A $100 million consumer fraud class action lawsuit has been filed against Galilee Memorial Gardens cemetery, its owners M.J. Edwards, N.J. Ford, and two well-known Memphis funeral homes, and any other funeral home that contracted business with Galilee Memorial Gardens after December 31, 2010, which is when its business license became invalid.
The funeral home lawsuit alleges the defendants lost bodies, disinterred bodies, stacked bodies/caskets on top of one another in single burial plots, crushed caskets to enable stacking more than one individual in a single burial plot, and lost track of remains and buried bodies, among other things.
Anyone who buried a body at Galilee Memorial Gardens after December 31, 2010 was doing so in violation of state law. Attorneys for the plaintiffs estimate at least 1,000 bodies were buried there in the past three years.
The lawsuit also states that funeral homes that conducted business with Galilee were on active and constructive notice that the individual who held the business license for the cemetery had died months before the license expired.
The lawsuit seeks to represent anyone with a loved one buried at Galilee Memorial Gardens in the past three years.
Hundreds of NuvaRing lawsuits are about to be settled by Merck & Co. The New Jersey based pharmaceutical company has agreed to pay $100 million to settle the lawsuits, and end allegations it downplayed serious health risks associated with the contraceptive device.
The NuvaRing agreement will settle cases in both federal and state courts, with plaintiffs expected to receive about $58,000 per complaint.
Currently, there are over 1,700 NuvaRing personal injury and defective product lawsuits pending against Merck. They allege the company failed to adequately warn women about the potential increased risk for developing dangerous blood clots known as venous thromboembolism associated with the device. Plaintiffs are seeking damages for a range of injuries allegedly caused by the birth control device, including heart attack, stroke and sudden death.
Available in the US since 2001, NuvaRing is one of several contraceptive products that have been linked to an increased risk of developing blood clots that can cause strokes and heart attacks. As of March 2012, approximately 12,000 lawsuits had been brought against Bayer HealthCare Pharmaceuticals, Inc., the manufacturer of Yasmin, Yaz, Beyaz and Safyral, alleging an increased risk of blood clots (deep vein thrombosis (DVT), pulmonary embolism (PE)) and gallbladder problems. Ocella, the generic version of Yasmin, is also associated with serious side effects, some of which are potentially fatal. In 2013, Bayer AG paid $1.6 billion to settle those lawsuits. If the $100 million figure Merck is supposedly to pay proves accurate, it will be a much smaller settlement.
Ok Folks, That’s all for this week. Happy Valentine’s Day! See you at the bar!